Agilent Technologies, Inc.
A- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001090872
In the last 90 days, Agilent Technologies, Inc. insiders filed 0 open-market purchases and 1 sale; 1,135 institutions reported holding it in 13F filings for Q2 2026, worth $34.6B in total; Greenhaven Associates is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Agilent Technologies, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1,013
- +8 vs. Q1 2024
- Shares held
- 254.5M
- −4.85M (−1.9%) vs. Q1 2024
- Total value
- $33.0B
- −$4.75B (−12.6%) vs. Q1 2024
- New holders
- 97
- 385 more added
- Sold out
- 89
- 350 more reduced
10 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting A on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1,135 | $34.6B |
| Q1 2026 | 1,077 | $28.9B |
| Q4 2025 | 1,149 | $34.9B |
| Q3 2025 | 1,042 | $32.2B |
| Q2 2025 | 1,010 | $30.1B |
| Q1 2025 | 1,023 | $29.6B |
| Q4 2024 | 1,079 | $34.0B |
| Q3 2024 | 1,054 | $37.2B |
| Q2 2024 | 1,013 | $33.0B |
| Q1 2024 | 1,015 | $37.9B |
| Q4 2023 | 1,007 | $35.7B |
| Q3 2023 | 920 | $28.3B |
| Q2 2023 | 940 | $30.9B |
| Q1 2023 | 987 | $36.2B |
| Q4 2022 | 966 | $38.7B |
| Q3 2022 | 898 | $31.3B |
| Q2 2022 | 887 | $30.6B |
| Q1 2022 | 933 | $34.7B |
| Q4 2021 | 984 | $42.0B |
| Q3 2021 | 945 | $41.5B |
| Q2 2021 | 887 | $38.9B |
| Q1 2021 | 874 | $33.2B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Agilent Technologies, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| SOA Wealth Advisors, LLC. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cambridge Trust Co | – | – | – | – | Not filed |
| Coulter & Justus Financial Services, LLC | – | – | – | – | Not filed |
| Fjarde Ap-Fonden /Fourth Swedish National Pension Fund | – | – | – | – | Not filed |
| Degroof Petercam Asset Management | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |
| Pflug Koory, LLC | – | – | – | – | Not filed |
| Grey Street Capital, LLC | – | – | – | – | Not filed |
| Watts Gwilliam & Co., LLC | – | – | – | – | Not filed |
| FSA Wealth Management LLC | – | – | – | – | Not filed |